Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1

Neuroscience and Biobehavioral Reviews

Volumn 26, Issue 3, 2002, Pages 353-359

  Paul, Robert ^a   Cohen, Ronald ^a   Navia, Bradford ^b   Tashima, Karen ^a  

^a MIRIAM HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Highly active antiretroviral therapy; Human immunodeficiency virus; Magnetic resonance imaging; Neuropsychology

Indexed keywords

BRAIN ATROPHY; BRAIN CORTEX; CAUDATE NUCLEUS; COGNITIVE DEFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGING; MEDICAL RESEARCH; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATROPHY; CAUDATE NUCLEUS; CEREBRAL CORTEX; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0036113318     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(02)00006-4     Document Type: Review

References (68)

1. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
2. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy
3. Highly active antiretroviral therapy for patients with AIDS dementia complex: Effect of MR imaging findings and clinical course
4. Regression of HIV encephalopathy and basal ganglia hyperintensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy
5. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy
6. Remission of AIDS-associated progressive multifocal leukoencephalopthy after cidofovir therapy
7. HIV-1-associated central nervous system dysfunction
8. AIDS dementia complex
9. Neuronal damage - Recent issues and implications for therapy
10. Mechanisms of HIV infection of the central nervous system and pathogenesis of AIDS-dementia complex
11. Neurobehavioral complications of HIV infection
12. Neurocognitive disorders seen in HIV disease
13. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-infection. Neuroradiological, neurophysiological, neuroimmunulogical, and virological correlates
14. Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1 infected brain
15. Brain imaging in acquired immunodeficiency syndrome dementia complex
16. CNS involvement in AIDS: Spectrum of CT and MR findings
17. Diagnostic imaging of the brain in acquired immunodeficiency syndrome (AIDS)
18. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with acquired immune deficiency syndrome (AIDS)
19. Reduced basal ganglia volume in HIV-1 associated dementia: Results from quantitative neuroimaging
20. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis
21. Morphollogy and distribution of HIV-1 gp141-positive microglia in subacute AIDS encephalitis
22. Neuropathology of human immunodeficiency virus infection
23. HIV dementia and the basal ganglia
24. AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations
25. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia
26. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center
27. Human immunodeficiency virus (HIV) infection and the nervous system: Report from the American Academy of Neurology AIDS Task Force
28. Dendritic injury is a pathologic substrate for HIV-related cognitive disorders
29. Fate of oligodendrocytes in HIV-1 infection
30. Neocortical damage during HIV infection
31. Clinical and biologic features of the AIDS dementia complex
32. Neuropsychological abnormalities among HIV-infected individuals in a community-based sample
33. Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1 infected individuals
34. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women
35. Cognitive deficits and emotional disorders in HIV-1 infected individuals
36. Decision-making speed in HIV-infection: A preliminary report
37. Neuropsychological performance in symptomatic and asymptomatic HIV infection
38. Frontal-subcortical circuits and human behavior
39. Pathological findings correlated with MRI in HIV infection
40. Acquired immunodeficiency syndrome: Magnetic resonance patterns of brain involvement with pathologic correlation
41. Encephalopathy in AIDS patients: Evaluation with MR imaging
42. Mild brain atrophy in early HIV infection: The lack of association with cognitive deficits and HIV-specific intrathecal immune response
43. CT, MR and pathology in AIDS encephalitis and meningits
44. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection
45. Radiological study of the brain at various stages of human immunodeficiency virus infection: Early development of brain atrophy
46. Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome
47. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-infected individuals
48. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection
49. White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study
50. Magnetic resonance imaging of white matter lesions in HIV infection
51. Cognitive decline in patients with symptomatic HIV-1 infection. No decline in asymptomatic infection
52. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects
53. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection
54. Patterns of cerebral atrophy in HIV-1-infected individuals: Results of a quantitative MRI analysis
55. Prospective cerebral MR study of HIV seropositive and seronegative men: Correlation of MR findings with neurologic, neuropsychologic, and cerebrospinal fluid analysis
56. Cognitive performance in HIV-1 infection: Relationship to severity of disease brain atrophy
57. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection
58. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection
59. Evidence of CNS impairment in HIV infection: Clinical, neuropsychological, EEG, and MRI/MRS study
60. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia
61. Regional brain atrophy in HIV-1 infection: Association with specific neuropsychological test performance
62. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenic relationship to the acquired immunodeficiency syndrome dementia complex
63. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia
64. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, prefrontal and limbic functions
65. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain
66. Neuronal damage in the cerebral cortex of AIDS brains: A morphometric study
67. Diffusion tensor imaging in HIV infection: What is it telling us?
68. Increased blood volume in HIV-positive patients detected by functional MRI